Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
about
Korean Guidelines for Interventional Recanalization of Lower Extremity ArteriesPrevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.Measures used to treat contrast-induced nephropathy: overview of reviewsProphylaxis of contrast-induced nephrotoxicityRadiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategiesRisks and complications of coronary angiography: a comprehensive reviewAnesthetic considerations for endovascular abdominal aortic aneurysm repairBridging Translation by Improving Preclinical Study Design in AKIAcute kidney injury: comment on "trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction".Antioxidant effect of Phyllanthus emblica extract prevents contrast-induced acute kidney injuryContrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience.Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.Developing practice recommendations for endovascular revascularization for acute ischemic stroke.Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarctionMechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol.Association between Glycosylated Haemoglobin Level and Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus.Acute kidney injury: quoi de neuf?Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial.Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary proceduresSCAI expert consensus statement: 2016 best practices in the cardiac catheterization laboratory: (Endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologia intervencionista; Affirmation of value by the Canadian AssoDrug-induced impairment of renal function.N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study.Preconditioning With Tauroursodeoxycholic Acid Protects Against Contrast-Induced HK-2 Cell Apoptosis by Inhibiting Endoplasmic Reticulum Stress.The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-AnalysisEvaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy.N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis.Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure.Exposure to Radiocontrast Agents Induces Pancreatic Inflammation by Activation of Nuclear Factor-κB, Calcium Signaling, and Calcineurin.Comparison of N-acetylcysteine, ascorbic acid, and normal saline effect in prevention of contrast-induced nephropathy.Effectiveness of N-Acetylcysteine for the Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPrevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysisEvaluation of the protective effect of N-acetylcysteine on contrast media nephropathyContrast-Induced Nephropathy After Computed Tomography in Stable CKD Patients With Proper Prophylaxis: 8-Year Experience of Outpatient Prophylaxis Program.Sodium Bicarbonate Prevents Contrast-Induced Nephropathy in Addition to Theophylline: A Randomized Controlled Trial.Crucial Roles of Systemic and Tissue Lipid Peroxidation Levels and Anti-Oxidant Defences Following Contrast Agent Application.Renal dysfunction and the associated decrease in survival after elective endovascular aneurysm repair.Heme oxygenase-1 counteracts contrast media-induced endothelial cell dysfunction.Pharmacological strategies to prevent contrast-induced acute kidney injury.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiN-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review.
P2860
Q26801709-8DEF33F1-9112-422D-A0FC-AB08807EED5BQ26823226-6FF26BA1-28B9-43BC-AC41-AD0D68207C9FQ26849704-90245990-0974-4694-9524-2AD022E5F8EDQ27012899-05BA0068-234B-4640-A4C2-DE6805D5D75BQ27021421-26C5F241-0DD1-47C3-B08D-C96440AD3950Q27025085-3E6DC87A-73FF-41ED-A197-32396E3B2A16Q28077099-B76BEEBE-4306-4B7B-A335-E9C2E2289FACQ28084530-291A377B-55D6-469C-AB6C-0D2B21E09F95Q33631923-EBE6641F-9967-4E41-9044-DA6059866A42Q33712773-927BA44E-18D0-4945-AC0C-DD381B530B7CQ33729371-A46E2EF3-8AE9-4EA9-A77E-B076415670BAQ33843623-77D52DA0-299D-4CA0-BAC7-C1298CBCAC93Q33943043-9B5FFE44-785F-48AE-B8C3-E4FBE5706403Q34011634-20D0B158-41C1-4842-BDD5-D50CABC9706AQ34150613-95799AD0-FB43-4B1D-B582-56BC1BE933AEQ34181042-DF215206-E50A-45C3-B3A4-B25A0413CC40Q34228579-6A1307BA-E381-4D0A-936B-A7FEE27C4AB6Q34257105-289A9E9C-E347-482B-B699-4E03C1A56B1FQ34523585-5FC2BA0E-5700-4D25-8A81-65638FD903B0Q34524667-9027EEED-D39C-4C84-B912-3F062A1BF458Q34731462-8ABA8657-D55D-4734-B29B-C6351B0E8A6DQ34753666-AA9DC5CB-5FB3-429D-937A-4F8CBCF4B573Q35589207-E6ACE3FC-A908-4668-B9D5-083201167A8AQ35666177-0F07EDB5-1939-495B-BBE0-CAEFB229F18AQ35762221-78F47E98-9C83-4174-820F-306F59ECD602Q35803600-06743E1D-CA16-4C19-B495-B9B4DADC6ABAQ35997843-6EB37330-E980-4BE5-B0A1-986E6FB80666Q35998360-8E934FE4-9A43-4DFE-B458-3C5BC0EAAA04Q36122228-66522132-F9B4-43DA-9DEC-F90F526FAFD5Q36143434-F4B155D8-ED7D-41CB-89DA-08ED6ADCF8E9Q36267436-B37F93C7-F177-422C-B712-3846088516C8Q36389997-3EB9C030-27C9-4117-9470-57283DDB16A9Q36891889-4283C6FA-DFB0-4867-8021-23F9324DCFA6Q36992907-05B23A4D-85A2-493B-B18E-71B5F165A35AQ37231140-3BAFF4B5-7E53-4860-BE8F-1EC7FFA53A01Q37365608-23335DEB-1E0C-4F8C-AA24-C4E3EC6155C6Q37626018-09839F43-6F69-41D3-8F66-C76976AA9F4DQ37639849-AE96F284-46D9-48C1-907B-41BE4C17739AQ37953885-3025245C-3E33-435D-9F1C-5ED18E73EA8EQ37977061-463B1E0C-6A13-414D-9F9E-A801D170136F
P2860
Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Acetylcysteine for prevention ...... duced nephropathy Trial (ACT).
@ast
Acetylcysteine for prevention ...... duced nephropathy Trial (ACT).
@en
Acetylcysteine for prevention ...... rast-induced nephropathy Trial
@nl
type
label
Acetylcysteine for prevention ...... duced nephropathy Trial (ACT).
@ast
Acetylcysteine for prevention ...... duced nephropathy Trial (ACT).
@en
Acetylcysteine for prevention ...... rast-induced nephropathy Trial
@nl
prefLabel
Acetylcysteine for prevention ...... duced nephropathy Trial (ACT).
@ast
Acetylcysteine for prevention ...... duced nephropathy Trial (ACT).
@en
Acetylcysteine for prevention ...... rast-induced nephropathy Trial
@nl
P1433
P1476
Acetylcysteine for prevention ...... duced nephropathy Trial (ACT).
@en
P2093
ACT Investigators
P304
P356
10.1161/CIRCULATIONAHA.111.038943
P407
P577
2011-08-22T00:00:00Z